Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisQuantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinomaProtein calorie malnutrition, nutritional intervention and personalized cancer care.Occupational exposure to trichloroethylene and serum concentrations of IL-6, IL-10, and TNF-alpha.Risk Factors of Non-Hodgkin LymphomaCerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphomaSignificance of Interleukin-6 in Papillary Thyroid Carcinoma.Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells.CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population.Occupational trichloroethylene exposure and risk of lymphatic and haematopoietic cancers: a meta-analysis.HLA-G peptide preferences change in transformed cells: impact on the binding motif.
P2860
Q26741263-6C644463-1207-4780-9B4F-1E8704D658FBQ28200526-534860E7-A8CA-40C0-8AC2-69C7352AFDBCQ33618955-6E63A691-38CB-4F3F-AC3F-62013B389C32Q35180423-DA24079C-6EBC-4667-958F-E63F6BDBD445Q35499320-D1699893-972F-4FBF-971C-F9E023836268Q35760627-6B99B89D-E6A0-4680-A4C8-2062DB2E7146Q36622888-D8DCE97D-0FBE-4430-8B31-F635A4F0D263Q36731164-53B7D0DD-24A8-44E8-9F85-DB5A9538BF8BQ37035532-8DCDED6D-C69D-4794-9063-117131779B9FQ38488118-9BC2FE14-6DBB-44D5-9B97-7D4734C86C8CQ39305171-7108E3D4-3150-4C8B-88EF-FEA9A1CABF6DQ39506851-D28B49C4-9900-4B60-A3CD-45533F481231Q40256511-BCE38F4A-30D3-4339-9292-6FF2CDDD5270Q48002956-6825F8F8-A5AF-4CFC-B69F-04358D78513AQ53076346-D594A627-FB7A-476F-9DF5-BFD4F970F995
P2860
Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Serum IL-10 and IL-6 levels at ...... ome in non-Hodgkin's lymphoma.
@en
type
label
Serum IL-10 and IL-6 levels at ...... ome in non-Hodgkin's lymphoma.
@en
prefLabel
Serum IL-10 and IL-6 levels at ...... ome in non-Hodgkin's lymphoma.
@en
P2093
P2860
P356
P1476
Serum IL-10 and IL-6 levels at ...... ome in non-Hodgkin's lymphoma.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03167070
P577
2004-12-01T00:00:00Z